Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Long-Term Investments (2020 - 2025)

Celularity has reported Long-Term Investments over the past 3 years, most recently at $2.9 million for Q3 2025.

  • Quarterly results put Long-Term Investments at $2.9 million for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was $2.9 million (changed N/A YoY), and the annual figure for FY2020 was $291.8 million, changed.
  • Long-Term Investments for Q3 2025 was $2.9 million at Celularity, down from $128.4 million in the prior quarter.
  • Over the last five years, Long-Term Investments for CELU hit a ceiling of $291.8 million in Q1 2021 and a floor of $2.9 million in Q3 2025.